Who are in the management team of Intercept Pharmaceuticals, Inc.?
As of March 2022, the management team of Intercept Pharmaceuticals, Inc. includes Mr. Paolo Fundaro (Independent Chairman), Mr. Jerome Durso (President and CEO), Mr. Gino Santini (Lead Independent Director), and several independent directors: Dr. Srinivas Akkaraju, Dr. Luca Benatti, Mr. Daniel Bradbury, and Dr. Keith Gottesdiener. The team features a blend of executive leadership and independent oversight.
As of March 2022, the management team of Intercept Pharmaceuticals, Inc. includes the following individuals:- Mr. Paolo Fundaro, who serves as the Independent Chairman of the Board.
- Mr. Jerome Durso, who is the President, Chief Executive Officer, Chief Operating Officer, and a Director.
- Mr. Gino Santini, who holds the position of Lead Independent Director.
- Dr. Srinivas Akkaraju, who is an Independent Director.
- Dr. Luca Benatti, who is also an Independent Director.
- Mr. Daniel Bradbury, serving as an Independent Director.
- Dr. Keith Gottesdiener, who is another Independent Director.
In summary, the management team comprises a mix of executive leadership and independent directors, highlighting a diverse governance structure.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
